Home Cart Sign in  
Chemical Structure| 2143475-98-1 Chemical Structure| 2143475-98-1

Structure of GeA-69
CAS No.: 2143475-98-1

Chemical Structure| 2143475-98-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GeA-69 is a selective PARP14 inhibitor with Kd value of 2.1 µM, targeting on macrodomain 2.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GeA-69

CAS No. :2143475-98-1
Formula : C20H16N2O
M.W : 300.35
SMILES Code : CC(NC1=CC=CC=C1C2=CC=CC3=C2NC4=C3C=CC=C4)=O
MDL No. :MFCD32067870
InChI Key :LDPDVNYCIOHPGF-UHFFFAOYSA-N
Pubchem ID :135397654

Safety of GeA-69

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GeA-69

epigenetics
DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U-2 OS cells 25 nM - 250 µM 72 hours To evaluate the cytotoxicity of GeA-69. Results showed that GeA-69 has moderate cytotoxicity with an EC50 of ~50 µM. ACS Chem Biol. 2017 Nov 17;12(11):2866-2874
HEK293 cells 25 nM - 250 µM 72 hours To evaluate the cytotoxicity of GeA-69. Results showed that GeA-69 has moderate cytotoxicity with an EC50 of ~50 µM. ACS Chem Biol. 2017 Nov 17;12(11):2866-2874
HeLa cells 25 nM - 250 µM 72 hours To evaluate the cytotoxicity of GeA-69. Results showed that GeA-69 has moderate cytotoxicity with an EC50 of ~50 µM. ACS Chem Biol. 2017 Nov 17;12(11):2866-2874

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.33mL

0.67mL

0.33mL

16.65mL

3.33mL

1.66mL

33.29mL

6.66mL

3.33mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories